VYLEESI is a prescription medicine used to treat hypoactive (low) sexual desire disorder (HSDD) in women who have not gone through menopause, who have not had problems with low sexual desire in the ...
While the expanded approval fulfills an unmet meet in postmenopausal women, its benefits are marginal in that population.
CRANBURY, N.J., Oct. 16, 2019 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) announced today that data from two pivotal, double-blind placebo-controlled Phase 3 trials (RECONNECT) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback